• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全血粘度评估问题二:内皮功能障碍和高凝状态的患病率

Whole blood viscosity assessment issues II: Prevalence in endothelial dysfunction and hypercoagulation.

作者信息

Nwose Ezekiel Uba

机构信息

Western Pathology Cluster - NSW HealthSouth West Pathology Service, 590 Smollett Street Albury, NSW 2640, Australia.

出版信息

N Am J Med Sci. 2010 Jun;2(6):252-7. doi: 10.4297/najms.2010.2252.

DOI:10.4297/najms.2010.2252
PMID:22574299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3347631/
Abstract

BACKGROUND

Virchow's triad in cardiovascular disease comprises blood viscosity, plasma D-dimer and homocysteine as indices of three associated but separate vascular phenomena.

AIMS

This work investigates prevalence of hyperviscosity in hyperhomocysteinaemia and positive D-dimer; and differences or similarities in stasis status among sub-populations of hyperhomocysteinaemia vs. normohomocysteinaemia and negative vs. positive D-dimer.

PATIENTS AND METHODS

10-years de-identified archived clinical pathology data for the period of January 1999 to December 2008 were audited. All cases tested for D-dimer (n=6845) and homocysteine (n=1665), which were concomitantly tested for haematocrit and total proteins, were extracted.

RESULTS

The results show a very low prevalence of hyperviscosity associated with a positive D-dimer sub-population (1.48%), which is not statistically different in comparison with the negative D-dimer sub-population. The prevalence of hyperviscosity associated with hyperhomocysteinaemia (5.04%) was statistically significantly higher in comparison to the normohomocysteinaemia sub-population (p = 0.05). The prevalence of low viscosity is significantly higher in the positive D-dimer sub-population relative to the negative D-dimer sub-population (p < 0.00001), but not different between hyperhomocysteinaemia vs. normohomocysteinaemia. Normoviscosity is statistically significantly commoner in normoviscosity relative to hyper-homocysteinaemia as well as in negative compared with positive D-dimer (p < 0.00001).

CONCLUSION

The findings reported here suggest putting into perspective the specificity of whole blood viscosity relative to stasis, not necessarily sensitivity to disease conditions where it is implicated.

摘要

背景

心血管疾病中的魏尔啸三联征包括血液粘度、血浆D - 二聚体和同型半胱氨酸,作为三种相关但不同的血管现象的指标。

目的

本研究调查高同型半胱氨酸血症和D - 二聚体阳性患者中高粘度的患病率;以及高同型半胱氨酸血症亚组与正常同型半胱氨酸血症亚组、D - 二聚体阴性与阳性亚组之间在血流淤滞状态上的差异或相似性。

患者和方法

审核了1999年1月至2008年12月期间10年的匿名存档临床病理数据。提取了所有检测D - 二聚体(n = 6845)和同型半胱氨酸(n = 1665)的病例,同时检测了血细胞比容和总蛋白。

结果

结果显示,与D - 二聚体阳性亚组相关的高粘度患病率非常低(1.48%),与D - 二聚体阴性亚组相比无统计学差异。与高同型半胱氨酸血症相关的高粘度患病率(5.04%)与正常同型半胱氨酸血症亚组相比有统计学显著差异(p = 0.05)。相对于D - 二聚体阴性亚组,D - 二聚体阳性亚组中低粘度的患病率显著更高(p < 0.00001),但高同型半胱氨酸血症与正常同型半胱氨酸血症之间无差异。相对于高同型半胱氨酸血症以及D - 二聚体阴性与阳性相比,正常粘度在正常粘度组中统计学上显著更常见(p < 0.00001)。

结论

此处报告的研究结果表明,应正确看待全血粘度相对于血流淤滞的特异性,而不一定是其对所涉及疾病状态的敏感性。

相似文献

1
Whole blood viscosity assessment issues II: Prevalence in endothelial dysfunction and hypercoagulation.全血粘度评估问题二:内皮功能障碍和高凝状态的患病率
N Am J Med Sci. 2010 Jun;2(6):252-7. doi: 10.4297/najms.2010.2252.
2
Whole blood viscosity assessment issues IV: Prevalence in acute phase inflammation.全血粘度评估问题IV:急性期炎症中的患病率。
N Am J Med Sci. 2010 Aug;2(8):353-8. doi: 10.4297/najms.2010.2353.
3
Whole blood viscosity assessment issues III: Association with international normalized ratio and thrombocytopenia.全血粘度评估问题III:与国际标准化比值和血小板减少症的关联。
N Am J Med Sci. 2010 Jul;2(7):301-5. doi: 10.4297/najms.2010.2301.
4
Whole blood viscosity assessment issues V: Prevalence in hypercreatinaemia, hyperglycaemia and hyperlipidaemia.全血粘度评估问题五:高肌酐血症、高血糖症和高脂血症中的患病率。
N Am J Med Sci. 2010 Sep;2(9):403-8. doi: 10.4297/najms.2010.2408.
5
Whole blood viscosity issues VI: Association with blood salicylate level and gastrointestinal bleeding.全血粘度问题六:与血液水杨酸盐水平及胃肠道出血的关联。
N Am J Med Sci. 2010 Oct;2(10):457-60. doi: 10.4297/najms.2010.2457.
6
Cardiovascular risks in prediabetes: preliminary data on "vasculopathy triad".糖尿病前期的心血管风险:关于“血管病变三联征”的初步数据。
N Am J Med Sci. 2014 Jul;6(7):328-32. doi: 10.4103/1947-2714.136913.
7
Whole blood viscosity issues VII: The correlation with leucocytosis and implication on leukapheresis.全血粘度问题VII:与白细胞增多症的相关性及对白细胞单采术的影响。
N Am J Med Sci. 2010 Dec;2(12):576-9. doi: 10.4297/najms.2010.2576.
8
Virchow's triad revisited: abnormal flow.重温魏尔啸三联征:血流异常。
Pathophysiol Haemost Thromb. 2003;33(5-6):455-7. doi: 10.1159/000083845.
9
Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease.高同型半胱氨酸血症中血管功能异常:与动脉粥样硬化血栓形成疾病的关系。
Eur J Pediatr. 1998 Apr;157 Suppl 2:S107-11. doi: 10.1007/pl00014293.
10
Virchow's triad in "silent" deep vein thrombosis.威克三(氏)三联征在“无声”深静脉血栓形成中的应用。
J Vasc Surg Venous Lymphat Disord. 2019 Sep;7(5):640-645. doi: 10.1016/j.jvsv.2019.02.011. Epub 2019 May 8.

引用本文的文献

1
Correlation Between Blood Coagulation Profile and Viscosity: Clinical Laboratory Observational Study.凝血指标与粘度之间的相关性:临床实验室观察性研究。
Med Sci (Basel). 2025 Feb 16;13(1):20. doi: 10.3390/medsci13010020.
2
Blood Viscosity Changes in Diabetes Mellitus: A 20-Year Bibliometric Review and Future Directions.糖尿病中的血液粘度变化:20年文献计量学综述与未来方向
Cureus. 2024 Jul 10;16(7):e64211. doi: 10.7759/cureus.64211. eCollection 2024 Jul.
3
Effectiveness and Safety of Fufang Danshen Dripping Pill (Cardiotonic Pill) on Blood Viscosity and Hemorheological Factors for Cardiovascular Event Prevention in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.

本文引用的文献

1
CARDIOVASCULAR RISK ASSESSMENT AND SUPPORT TECHNIQUES: Whole blood viscosity assessment issues I: Extrapolation chart and reference values.心血管风险评估与支持技术:全血粘度评估问题I:外推图和参考值
N Am J Med Sci. 2010 Apr;2(4):165-9. doi: 10.4297/najms.2010.2165.
2
Homocysteine modifies fibrin clot deformability: another possible explanation of harm.同型半胱氨酸改变纤维蛋白凝块的可变形性:危害的另一种可能解释。
Biorheology. 2009;46(5):379-87. doi: 10.3233/BIR-2009-0459.
3
Hypercoagulability and thrombotic complications in hemolytic anemias.
复方丹参滴丸(通心络胶囊)对 2 型糖尿病患者心血管事件预防的血液黏度和血液流变学因素的有效性和安全性:系统评价和荟萃分析。
Medicina (Kaunas). 2023 Sep 27;59(10):1730. doi: 10.3390/medicina59101730.
4
Whole blood viscosity assessment issues IV: Prevalence in acute phase inflammation.全血粘度评估问题IV:急性期炎症中的患病率。
N Am J Med Sci. 2010 Aug;2(8):353-8. doi: 10.4297/najms.2010.2353.
5
Whole blood viscosity assessment issues V: Prevalence in hypercreatinaemia, hyperglycaemia and hyperlipidaemia.全血粘度评估问题五:高肌酐血症、高血糖症和高脂血症中的患病率。
N Am J Med Sci. 2010 Sep;2(9):403-8. doi: 10.4297/najms.2010.2408.
6
Whole blood viscosity issues VII: The correlation with leucocytosis and implication on leukapheresis.全血粘度问题VII:与白细胞增多症的相关性及对白细胞单采术的影响。
N Am J Med Sci. 2010 Dec;2(12):576-9. doi: 10.4297/najms.2010.2576.
溶血性贫血中的高凝状态和血栓并发症。
Haematologica. 2009 Nov;94(11):1481-4. doi: 10.3324/haematol.2009.013672.
4
Is 'Virchow's triad' useful?“魏尔啸氏三要素”有用吗?
Br J Haematol. 2009 Jun;145(6):839; author reply 840-1. doi: 10.1111/j.1365-2141.2009.07685.x. Epub 2009 Mar 30.
5
Nuclear medicine and diabetic foot infections.核医学与糖尿病足感染
Semin Nucl Med. 2009 Jan;39(1):52-65. doi: 10.1053/j.semnuclmed.2008.08.006.
6
Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study.血液粘度和血细胞比容作为2型糖尿病的风险因素:社区动脉粥样硬化风险(ARIC)研究
Am J Epidemiol. 2008 Nov 15;168(10):1153-60. doi: 10.1093/aje/kwn243. Epub 2008 Oct 17.
7
Virchow and his triad: a question of attribution.魏尔啸及其三联征:归因问题。
Br J Haematol. 2008 Oct;143(2):180-90. doi: 10.1111/j.1365-2141.2008.07323.x. Epub 2008 Sep 6.
8
Portal vein thrombosis as the first sign of nephrotic syndrome.门静脉血栓形成作为肾病综合征的首发表现
Nat Clin Pract Nephrol. 2008 Jun;4(6):342-5. doi: 10.1038/ncpneph0810. Epub 2008 May 6.
9
Deep vein thrombosis--a rare post transplant complication.深静脉血栓形成——一种罕见的移植后并发症。
J Pak Med Assoc. 2007 Oct;57(10):515-6.
10
Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications.糖尿病及其心血管并发症临床管理中的红细胞氧化应激
Br J Biomed Sci. 2007;64(1):35-43. doi: 10.1080/09674845.2007.11732754.